###begin article-title 0
Ankyrin-B Syndrome: Enhanced Cardiac Function Balanced by Risk of Cardiac Death and Premature Senescence
###end article-title 0
###begin p 1
Conceived and designed the experiments: VB AP PM JH HR CK RA. Performed the experiments: VB AP PM JH HX HR CK RA. Analyzed the data: VB EK AP PM JH HX HR CK RA. Contributed reagents/materials/analysis tools: VB EK AP PM JH HX HR CK RA. Wrote the paper: VB EK AP PM JH CK RA. Other: Designed the study: PM. Wrote the first draft of the paper: PM.
###end p 1
###begin p 2
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANK2</italic>
###xml 150 154 150 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANK2</italic>
###xml 460 468 460 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 532 535 532 535 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 52 57 <span type="species:ncbi:9606">human</span>
###xml 108 113 <span type="species:ncbi:9606">human</span>
###xml 317 322 <span type="species:ncbi:9606">human</span>
###xml 536 541 <span type="species:ncbi:10090">mouse</span>
Here we report the unexpected finding that specific human ANK2 variants represent a new example of balanced human variants. The prevalence of certain ANK2 (encodes ankyrin-B) variants range from 2 percent of European individuals to 8 percent in individuals from West Africa. Ankyrin-B variants associated with severe human arrhythmia phenotypes (eg E1425G, V1516D, R1788W) were rare in the general population. Variants associated with less severe clinical and in vitro phenotypes were unexpectedly common. Studies with the ankyrin-B+/- mouse reveal both benefits of enhanced cardiac contractility, as well as costs in earlier senescence and reduced lifespan. Together these findings suggest a constellation of traits that we term "ankyrin-B syndrome", which may contribute to both aging-related disorders and enhanced cardiac function.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 204 207 204 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Bennett1">[1]</xref>
###xml 208 211 208 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Bennett3">[3]</xref>
###xml 406 409 406 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Agre1">[4]</xref>
###xml 410 413 410 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Eber1">[6]</xref>
###xml 749 752 749 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Jenkins1">[7]</xref>
###xml 754 757 754 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Zhou1">[8]</xref>
###xml 802 805 802 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Mohler1">[9]</xref>
###xml 846 851 846 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCN5A</italic>
###xml 894 895 894 895 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</sub>
###xml 1003 1006 1003 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Mohler1">[9]</xref>
###xml 1123 1127 1123 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Kizhatil1">[10]</xref>
###xml 1129 1133 1129 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Kizhatil2">[11]</xref>
###xml 1373 1377 1373 1377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Scotland1">[12]</xref>
###xml 185 190 <span type="species:ncbi:9606">human</span>
###xml 399 405 <span type="species:ncbi:9606">humans</span>
###xml 852 857 <span type="species:ncbi:9606">human</span>
###xml 1338 1342 <span type="species:ncbi:10090">mice</span>
Ankyrins -R, -B, and -G are a versatile family of membrane-associated adaptors that were first discovered based on the role of ankyrin-R in mediating membrane attachment of spectrin in human erythrocytes [1]-[3]. Consistent with this function, mutations in ankyrin-R are the major cause of hereditary spherocytosis, a disorder associated with spectrin deficiency and increased membrane fragility in humans [4]-[6]. Ankyrins-G and -B are expressed in non-erythroid tissues, where they function in the maintenance and establishment of specialized membrane domains by interacting with a diverse set of membrane proteins. Ankyrin-G is required for accumulation of voltage-gated sodium channels in excitable membranes at axon initial segments of neurons [7], [8] and at transverse-tubules in cardiomyocytes [9]. A cardiac voltage-gated sodium channel SCN5A human variant that abolishes binding of Nav1.5 with to ankyrin-G results in Brugada syndrome, which is a dominantly-inherited fatal cardiac arrhythmia [9]. Ankyrin-G also is required for biogenesis of the lateral membrane of epithelial cells and pre-implantation embryos [10], [11]. Loss of ankyrin-G function thus would likely have major consequences beginning in early development. In contrast to ankyrin-G, ankyrin-B has more specialized roles, and is required for postnatal life in mice but not for prenatal survival [12].
###end p 4
###begin p 5
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANK2</italic>
###xml 282 286 282 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Mohler2">[13]</xref>
###xml 287 291 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Mohler4">[15]</xref>
###xml 471 475 471 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Mohler3">[14]</xref>
###xml 499 502 499 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 667 671 667 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Mohler3">[14]</xref>
###xml 733 736 733 736 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 955 959 955 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Mohler5">[16]</xref>
###xml 1014 1017 1014 1017 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1093 1097 1093 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Bhasin1">[17]</xref>
###xml 300 304 <span type="species:ncbi:10090">Mice</span>
###xml 380 386 <span type="species:ncbi:9606">humans</span>
Loss-of-function variants in ANK2 (encodes ankyrin-B) cause a dominantly-inherited cardiac arrhythmia with increased risk for sudden cardiac death, initially termed type 4 long QT syndrome, and more recently renamed sick sinus syndrome with bradycardia or the "ankyrin-B syndrome" ([13]-[15]; OMIM). Mice heterozygous for a null mutation in ankyrin-B have a similar arrhythmia to humans and exhibit sudden death following administration of catecholamines and/or exercise [14]. Studies with ankyrin-B+/- cardiomyocytes revealed that the basis for sudden death associated with the arrhythmia is elevation of calcium transients in the context of sympathetic stimulation [14]. The cellular basis for altered calcium dynamics in ankyrin-B+/- cardiomyocytes has been proposed to result from a deficiency of a complex of ankyrin-B with the Na/K ATPase, Na/Ca exchanger, and IP3 receptor localized in a specialized microdomain in cardiomyocyte transverse-tubules [16]. Loss of additional signaling molecules from ankyrin-B+/- myocytes may also influence the cellular phenotype in ankyrin-B deficiency [17].
###end p 5
###begin p 6
###xml 38 41 38 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 194 198 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Mohler2">[13]</xref>
###xml 200 204 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Mohler3">[14]</xref>
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Mohler6">[18]</xref>
###xml 278 286 278 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 345 349 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Priori1">[19]</xref>
###xml 351 355 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Roden1">[20]</xref>
###xml 703 707 703 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Mohler3">[14]</xref>
###xml 844 848 844 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Sherman1">[21]</xref>
###xml 108 113 <span type="species:ncbi:9606">human</span>
###xml 826 831 <span type="species:ncbi:9606">human</span>
Abnormal calcium dynamics in ankyrin-B+/- neonatal cardiomyocytes can be rescued by expression of wild-type human ankyrin-B but not by ankyrin-B with variants associated with cardiac arrhythmia [13], [14], [18]. These ankyrin-B variants demonstrate clear functional differences in vitro. However, similar to other inherited arrhythmia syndromes [19], [20], the penetrance of the sudden cardiac death phenotype in families with ankyrin-B variants can be relatively low. For example, in the first family studied with the E1425G variant, while numerous individuals displayed sinus node dysfunction, atrial fibrillation, and ventricular arrhythmia, only 2 of the 21 heterozygotes experienced fatal outcomes [14]. Moreover, specific ankyrin-B variants associated with minor cellular phenotypes may be relatively common in specific human populations [21].
###end p 6
###begin p 7
###xml 355 358 355 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 107 113 <span type="species:ncbi:9606">humans</span>
###xml 359 364 <span type="species:ncbi:10090">mouse</span>
Here, we present evidence that specific ankyrin-B variants represent a new example of balanced variants in humans. The prevalence of ankyrin-B variants varied from 2 percent of European to 8 percent in individuals from West Africa. Moreover, African and European populations also exhibit distinct patterns of ankyrin-B variants. Studies with the ankyrin-B+/- mouse reveal both benefits of enhanced cardiac contractility, as well as costs in earlier senescence and reduced lifespan. Together these findings suggest a constellation of traits that we term "ankyrin-B syndrome", which may contribute to both aging-related disorders and enhanced cardiac function.
###end p 7
###begin title 8
Materials and Methods
###end title 8
###begin title 9
Protein Alignment
###end title 9
###begin p 10
###xml 95 107 95 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Homo sapiens</italic>
###xml 136 150 136 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Macaca mulatta</italic>
###xml 184 200 184 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Canis familiaris</italic>
###xml 230 242 230 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mus musculus</italic>
###xml 271 288 271 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rattus norvegicus</italic>
###xml 323 338 323 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pan troglodytes</italic>
###xml 369 382 369 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gallus gallus</italic>
###xml 95 107 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 136 150 <span type="species:ncbi:9544">Macaca mulatta</span>
###xml 184 200 <span type="species:ncbi:9615">Canis familiaris</span>
###xml 230 242 <span type="species:ncbi:10090">Mus musculus</span>
###xml 271 288 <span type="species:ncbi:10116">Rattus norvegicus</span>
###xml 323 338 <span type="species:ncbi:9598">Pan troglodytes</span>
###xml 369 382 <span type="species:ncbi:9031">Gallus gallus</span>
Protein alignments were performed in CLUSTALW using the following protein sequences from NCBI: Homo sapiens gi|119626696|gb|EAX06291.1; Macaca mulatta gi|109075425|ref|XP_001095471.1; Canis familiaris gi|74002173|ref|XP_545031.2; Mus musculus gi|37590265|gb|AAH59251.1|; Rattus norvegicus gi|109467596|ref|XP_001076082.1|; Pan troglodytes gi|114595754|ref|XP_517403.2; Gallus gallus gi|118090374|ref|XP_420641.2.
###end p 10
###begin title 11
Genetic Studies
###end title 11
###begin p 12
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANK2</italic>
ANK2 variants reported previously to have functional consequences in cardiomyocytes were used for genotyping genomic DNA samples from West Africans residing in the country of Ghana (collected by Rand Allingham and co-workers, Duke University Dept. of Ophthalmology) and Europeans (collected by the Associazone Longevita, Italy). SNP genotyping was determined using the ABI 7900HT Taqman SNP genotyping system (Applied Biosystems, Foster City, California, United States), which uses a PCR-based allelic discrimination assay in a 384-well-plate format with a dual laser scanner. Allelic discrimination assays were purchased from Applied Biosystems, or, if the assays were not available, primer and probe sets were designed and purchased through Integrated DNA Technologies (Coralville, IA,). Successful genotyping was obtained for greater than 95% of the DNA samples used in the study.
###end p 12
###begin title 13
Animal care
###end title 13
###begin p 14
###xml 9 12 9 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 18 22 18 22 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Scotland1">[12]</xref>
###xml 130 133 130 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
###xml 586 590 <span type="species:ncbi:10090">mice</span>
Ankyrin-B+/- mice [12] were backcrossed >10 generations (>99.5% pure) into a C57/Bl6 background before experiments. Both ankyrin-B+/- and wild-type littermates mice were housed in the same facility (temperature and humidity), consumed the same diet (Lab Diet, 23% protein, 4.5% fat, 6.0% fiber, 8.0% ash, 2.5% minerals (0.95% Ca2+, 0.67% phosphorus, 0.40% non-phytate phosphorus), 56% complex carbohydrate from overhead wire feeders) and water ad libitum, and were kept on identical 12 hour light/dark cycle. Food intake was monitored over 24 hour periods and averaged over 2-3 days in mice individually housed.
###end p 14
###begin title 15
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
3H ouabain-binding
###end title 15
###begin p 16
###xml 13 14 13 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
Equilibrium [3H] ouabain binding was performed on isolated live adult cardiomyocytes (>70% rod-shaped) for 60 min at 35degreesC in modified Tyrode's buffer (0.5 mM KCl). Non-specific binding was determined as binding in the presence of 10 mM non-radioactive ouabain. Membranes were separated from buffer and sequentially washed by vacuum filtration in cold buffer followed by liquid scintillation counting.
###end p 16
###begin title 17
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse echocardiograms
###end title 17
###begin p 18
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Rockman1">[22]</xref>
###xml 143 147 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Rockman2">[25]</xref>
###xml 248 252 248 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Esposito1">[23]</xref>
###xml 624 628 624 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Esposito1">[23]</xref>
###xml 630 634 630 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Perrino1">[26]</xref>
###xml 768 771 768 771 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 815 819 815 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Esposito1">[23]</xref>
###xml 821 825 821 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Perrino1">[26]</xref>
###xml 901 904 901 904 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 149 153 <span type="species:ncbi:10090">Mice</span>
###xml 336 340 <span type="species:ncbi:10090">Mice</span>
###xml 423 427 <span type="species:ncbi:10090">mice</span>
###xml 667 671 <span type="species:ncbi:10090">mice</span>
###xml 772 776 <span type="species:ncbi:10090">mice</span>
###xml 905 909 <span type="species:ncbi:10090">mice</span>
Two-dimensional guided M-mode echocardiography was performed using an HDI 5000 echocardiograph (ATL, Bothell, WA) as previously described [22]-[25]. Mice were studied in a conscious state using gentle manual restraint after a period of acclimation [23]. A soft plastic collar was fashioned to prevent the animals from biting the probe. Mice were studied in a conscious state. For pressure overload induced cardiac failure, mice were anesthetized, intubated; the chest was opened in the second intercostal space. A 7-0 suture was placed around the transverse aorta and tied to a 27 gauge needle to create aortic constriction [23], [26]. The needle was then recovered, mice were allowed to recover, and follow-up echocardiograms were performed on wild-type and ankyrin-B+/- mice seven days post-ligation as described [23], [26]. Fractional shortening values were compared between wild-type and ankyrin-B+/- mice over a range of similar pressure gradients. Values represent mean+/-standard error.
###end p 18
###begin title 19
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse studies
###end title 19
###begin p 20
###xml 92 95 92 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 157 161 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Mohler3">[14]</xref>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
###xml 296 300 <span type="species:ncbi:10090">mice</span>
Animal care was in accordance with institutional guidelines. Wild-type (n = 6) and ankyrin-B+/- mice (n = 6) were implanted with radiotelemetry transmitters [14]. Following an intraperitoneal injection of a low (100 microg/kg) or high dose (10 mg/kg) of ouabain, or 2 mg/kg epinephrine conscious mice were monitored for heart rate, syncope, or death.
###end p 20
###begin title 21
Preparation of Adult Cardiac Myocytes and Contractility Studies
###end title 21
###begin p 22
###xml 74 77 74 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 122 125 122 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-BarkiHarrington1">[27]</xref>
###xml 627 631 623 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-BarkiHarrington1">[27]</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 56 60 <span type="species:ncbi:10090">mice</span>
###xml 311 316 <span type="species:ncbi:10090">Mouse</span>
###xml 698 703 <span type="species:ncbi:10090">mouse</span>
###xml 750 755 <span type="species:ncbi:10090">mouse</span>
###xml 861 865 <span type="species:ncbi:10090">mice</span>
Mice used in these studies were female adult WT C57BL/6 mice and ankyrin-B+/- littermates (C57 BL/6), or wild-type and PLN-/- littermates (129), 3-6 months of age and weighing 30-40 g. Animals were handled according to approved protocols and animal welfare regulations of the Institutional Review Board (DUMC). Mouse ventricular cardiomyocytes were isolated as described in [27]. Myocytes were isolated and visualized with an inverted microscope (Nikon Eclipse TE 300). Single-cell contraction was measured by video edge detection, and recordings were made under basal conditions and after administration of 100 microM ouabain [27]. Cellular shortening was measured for 15-20 cells of equal length/mouse to determine the mean cellular shortening per mouse under each condition. Values reported represent mean+/-standard deviation of cellular shortening for 4-5 mice.
###end p 22
###begin title 23
Temperature measurements
###end title 23
###begin p 24
###xml 32 36 <span type="species:ncbi:10090">mice</span>
Following anesthesia, six month mice were surgically implanted with radiotelemetry temperature probes (Data Sciences International). Five days after surgery, the temperature of non-anesthetized animals was determined.
###end p 24
###begin title 25
Immunofluorescence and Immunoblotting
###end title 25
###begin p 26
###xml 62 65 62 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
Freshly extracted pancreas from wild-type C57B/6 and ankyrin-B+/- C57B/6 mice was fixed for 18 hours at 4degreesC in 4% paraformaldehyde. Tissues were embedded and sectioned at 10 microm thickness. Primary antibody incubation was performed for 18 hours at 4degreesC and slides were washed thoroughly with a solution of phosphate buffered saline, pH 7.4 (PBS) +0.1% Triton X-100 (v/v). Incubation with secondary antibodies was performed for six hours at 4degreesC and slides were again washed with PBS +0.1% (v/v) Triton X-100. Pancreas sections were analyzed using the following antibodies: insulin (Santa Cruz, Chemicon) glucagon (Sigma), somatostatin (Chemicon), and ankyrin-B.
###end p 26
###begin title 27
Antibodies
###end title 27
###begin p 28
###xml 28 34 <span type="species:ncbi:9986">rabbit</span>
###xml 76 82 <span type="species:ncbi:9986">rabbit</span>
###xml 127 132 <span type="species:ncbi:10090">mouse</span>
###xml 244 248 <span type="species:ncbi:9925">goat</span>
###xml 254 260 <span type="species:ncbi:9986">rabbit</span>
###xml 265 269 <span type="species:ncbi:9925">goat</span>
###xml 275 280 <span type="species:ncbi:10090">mouse</span>
Primary antibodies included rabbit anti-insulin (Santa Cruz Biotechnology); rabbit anti-somatostatin (Chemicon International); mouse anti-glucagon (Sigma); affinity-purified ankyrin-B monoclonal and polyclonal Ig. Secondary antibodies included goat anti-rabbit and goat anti-mouse Alexa Fluor 488 and 568 (Molecular Probes).
###end p 28
###begin title 29
Survival Curve
###end title 29
###begin p 30
###xml 9 12 9 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 295 298 295 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
###xml 332 336 <span type="species:ncbi:10090">mice</span>
Ankyrin-B+/- mice (n = 100) and their wild-type littermates (n = 100) (C57B/6) were monitored for three years. Each group of mice were kept in identical environments. Relative survival for each genotype was calculated as a per cent cumulative survival of its group (either wild-type or ankyrin-B+/-). Evaluation continued until all mice within each population died (0% survival).
###end p 30
###begin title 31
Immunoblotting
###end title 31
###begin p 32
###xml 50 54 50 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Scotland1">[12]</xref>
###xml 246 250 240 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Scotland1">[12]</xref>
###xml 257 260 251 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
Immunoblots were performed as previously described[12]. Primary antibody incubation was performed for 18 hours at 4degreesC with gentle rocking. Blots were rinsed using three 15-minute washes in 1x TTBS. Immunoblotting was performed as described [12] using 125I-labelled Protein A. Signals were quantitated by phosphorimaging.
###end p 32
###begin title 33
Statistics
###end title 33
###begin p 34
###xml 50 51 50 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 80 81 80 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Data were analyzed using either paired two-tailed t tests or two-way ANOVA, and P values less than 0.05 were considered significant (*).
###end p 34
###begin title 35
Results
###end title 35
###begin title 36
###xml 36 41 <span type="species:ncbi:9606">human</span>
Prevalence of ankyrin-B variants in human populations
###end title 36
###begin p 37
###xml 139 143 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Mohler3">[14]</xref>
###xml 145 149 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Mohler4">[15]</xref>
###xml 217 221 217 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Mohler3">[14]</xref>
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Mohler4">[15]</xref>
###xml 302 311 302 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g001">Figure 1B</xref>
###xml 798 802 798 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Sherman1">[21]</xref>
###xml 55 63 <span type="species:ncbi:9606">patients</span>
###xml 466 472 <span type="species:ncbi:9606">humans</span>
###xml 476 484 <span type="species:ncbi:9031">chickens</span>
An initial screen for ankyrin-B variants in arrhythmia patients detected individuals with several mis-sense variants in the ankyrin-B gene [14], [15]. These variants include E1425G, L1622I, T1626N, R1788W, and E1813K [14], [15]. Comparison of ankyrin-B protein primary sequence from different species (Figure 1B) shows that the identified variants are highly conserved in vertebrates. Of the six variants shown, only T1626N does not show 100% sequence identity from humans to chickens. The high degree of conservation across species suggests that these residues are likely to be critical for ankyrin-B stability and/or function. It was therefore unexpected when Sherman and colleagues reported that certain ankyrin-B gene variants were present in healthy Caucasian and African American individuals [21]. Notably, L1622I was found in 4% of African-Americans in this study. One intriguing possibility is that the apparent discrepancy is due to ethnic differences in ankyrin-B SNP allele frequency.
###end p 37
###begin title 38
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human ankyrin-B gene variants have unique distributions in distinct ethnic populations and may affect longevity.
###end title 38
###begin p 39
###xml 628 632 628 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANK2</italic>
###xml 309 314 <span type="species:ncbi:10090">mouse</span>
###xml 482 487 <span type="species:ncbi:9606">human</span>
###xml 497 500 <span type="species:ncbi:10116">rat</span>
###xml 502 507 <span type="species:ncbi:10090">mouse</span>
###xml 509 512 <span type="species:ncbi:9615">dog</span>
###xml 514 521 <span type="species:ncbi:9031">chicken</span>
###xml 527 536 <span type="species:ncbi:7955">zebrafish</span>
A. The domain structure of 220 kD ankyrin-B protein, showing the N-terminal membrane binding domain (red), spectrin-binding domain (green), death domain (yellow), and C-terminal domain (blue). Magnified insert shows the location of previously identified variants. Variants had range of functional severity in mouse cardiomyocytes, indicated with yellow (mild), gray (moderate) or red (severe) bars. B. Affected residues are highly conserved across species. Ankyrin-B alignment from human, monkey, rat, mouse, dog, chicken, and zebrafish. Residues affected by the nucleotide variants are shown in red. C. Allele frequency of the ANK2 variants in 1152 Europeans (black bars) and 384 West Africans (red bars) as determined by PCR based allelic discrimination assay. Right, Allele frequency of pooled functional variants. D. Ankyrin-B variants are less frequent in Europeans that reach the age of 100. Allele frequency of the each variant in European non-centenarians (black bars) and centenarians (red bars). Asterisks indicate that no individuals were identified with the variant.
###end p 39
###begin p 40
Thus, we first determined the allele frequencies of these genetic variants in defined ethnic populations. We decided to explore the differences between white and black populations. In order to do this, we obtained genomic DNA samples from European and African populations. Since African-Americans represent an admixture of Caucasian, African, and Native American haplotypes that would confound our analysis, we chose to exclude them from this initial study.
###end p 40
###begin p 41
###xml 108 117 108 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g001">Figure 1c</xref>
We genotyped 384 west African and 1152 European individuals using a PCR-based allelic discrimination assay. Figure 1c shows the allele frequency of each variant in the European (black) and west African (red) populations tested, as well as the allele frequency of the pooled functional variants (Total). L1622I was surprisingly common in Africans, and was present in approximately8.6% of the individuals genotyped. It was the only variant detected in the west African population. In the European population, all SNPs had an allele frequency of less than 0.01, though combined, 2.1% of the European sample had a loss of function ankyrin B variant.
###end p 41
###begin p 42
###xml 29 32 29 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 559 568 559 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g001">Figure 1D</xref>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 349 355 <span type="species:ncbi:9606">humans</span>
###xml 1314 1322 <span type="species:ncbi:9606">patients</span>
As discussed later, ankyrin-B+/- mice demonstrate signs of accelerated senescence compared to litter matched controls (see below). Using population tools, we next evaluated whether there were negative consequences for longevity in individuals with ankyrin-B variants. If so, we would predict these variants to be depleted or absent in centenarians (humans that reach the age of 100). The European genomic DNA samples used in the population study were a collection of 768 centenarians and 384 non-centenarians obtained from the Associazone Longevita in Italy. Figure 1D shows the allele frequency of the each variant in non-centenarians (black) and centenarians (red). Centenarians had a reduced frequency of variants at 1.6 percent compared to non-centenarians with 2.4 percent. However, the association between ankyrin-B variants and centenarian status was not significant (for combined ankyrin-B loss-of-function variants p = 0.3570 for Fischer's exact test, p = 0.3501 for chi-squared test). However, we believe that the high p value is likely to result from a lack of power at this sample size. Given the low allele frequency of these variants, the p value could be improved by increasing the numbers of individuals tested in each group. At the proportions seen in this study, we would need approximately 6000 patients to get a significant p value. We hope to address this study limitation in the future.
###end p 42
###begin p 43
These data indicate that specific ankyrin-B gene variants are both more common than expected and segregated with respect to ethnicity. Negative consequences for those having a function ankyrin-B variant may include both susceptibility to cardiac arrhythmia and reduced longevity. However, the prevalence of these variants and racial differences detected in their frequency suggest the interesting possibility that these ankyrin-B variants may benefit organism survival.
###end p 43
###begin title 44
###xml 36 39 36 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
Increased contractility of ankyrin-B+/- cardiomyocytes
###end title 44
###begin p 45
###xml 101 104 101 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 173 177 173 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Mohler3">[14]</xref>
###xml 315 316 315 316 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 326 330 326 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Mohler5">[16]</xref>
###xml 85 90 <span type="species:ncbi:10090">mouse</span>
We next explored whether ankyrin-B haploinsufficiency could provide a benefit to the mouse. Ankyrin-B+/- cardiomyocytes exhibit a 16 percent elevation in calcium transients [14], which has been proposed to result from loss of Na/K ATPase localized in a complex with ankyrin-B as well as the Na/Ca exchanger and InsP3 receptor [16]. Elevated intracellular calcium transients in ventricular cardiomyocytes would lead to enhanced contractility, which would increase cardiac output. These findings suggested the hypothesis that ankyrin-B deficiency mimics effects of cardiac glycosides, which inhibit the Na/K ATPase, cause elevation in intracellular calcium stores, and increase cardiac contractility as a positive outcome.
###end p 45
###begin p 46
###xml 137 140 137 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 241 243 241 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 244 245 244 245 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 542 551 526 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g002">Figure 2A</xref>
###xml 584 587 568 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 744 747 728 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 864 873 832 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g002">Figure 2A</xref>
###xml 903 906 871 874 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1104 1107 1072 1075 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1240 1243 1208 1211 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 424 428 <span type="species:ncbi:10090">mice</span>
###xml 641 645 <span type="species:ncbi:10090">mice</span>
We first compared effects of ouabain and ankyrin-B-deficiency on cellular shortening in freshly isolated unloaded wild-type and ankyrin-B+/- adult ventricular cardiomyocytes. The extent of cell shortening provides a functional readout of [Ca2+]i transients and contractility, since cardiomyocytes respond to elevated calcium levels by contraction. Field-stimulated wild-type cardiomyocytes exhibited 12.3% shortening (n = 5 mice) that increased approximately1.7-fold to 20% in the presence of 100 microM ouabain (a saturating concentration) (Figure 2A, p<0.01). In contrast, ankyrin-B+/- cardiomyocytes exhibited 15% basal shortening (n = 4 mice), a value significantly greater than that of unloaded wild-type cardiomyocytes (p<0.01). Ankyrin-B+/- cardiomyocytes were further activated by 100 microM ouabain to 20% shortening, or a approximately1.3-fold increase (Figure 2A, p<0.01). Untreated ankyrin-B+/- cardiomyocytes thus behave as if they were treated with ouabain, with increased basal levels of contraction. In response to treatment with maximal concentrations of ouabain, wild-type and ankyrin-B+/- cardiomyocytes are activated to the same final extent. These results suggested that the fraction of Na/K ATPase missing in ankyrin-B+/- cardiomyocytes accounts for approximately38% of the maximal contractile response to ouabain.
###end p 46
###begin title 47
###xml 29 30 29 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
Loss of ankyrin-B-dependent [3H]-ouabain-binding sites mimics the cellular action of digitalis.
###end title 47
###begin p 48
###xml 31 34 31 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 169 171 169 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 172 173 172 173 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 185 189 185 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Mohler3">[14]</xref>
###xml 252 255 252 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 325 328 325 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 489 492 485 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 595 598 591 594 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 695 696 679 680 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 782 785 766 769 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 914 917 898 901 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 933 936 917 920 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 302 306 <span type="species:ncbi:10090">mice</span>
###xml 539 543 <span type="species:ncbi:10090">mice</span>
###xml 786 790 <span type="species:ncbi:10090">mice</span>
###xml 937 941 <span type="species:ncbi:10090">mice</span>
###xml 1001 1005 <span type="species:ncbi:10090">mice</span>
(A) Isolated unloaded ankyrin-B+/- ventricular cardiomyocytes display increased cellular shortening compared to unloaded WT cardiomyocytes, consistent with increased [Ca2+]i transients [14]. Asterisk represents p<0.01 between untreated WT and ankyrin-B+/- cardiomyocytes (15-20 cardiomyocytes from 4-5 mice). WT and ankyrin-B+/- cardiomyocytes treated with maximal doses of ouabain (100 microM) display significant elevations in cellular shortening compared with untreated WT and ankyrin-B+/- cardiomyocytes (15-20 cardiomyocytes from 4-5 mice, p<0.01, asterisks). (B-C) Live, isolated ankyrin-B+/- cardiomyocytes display reduced (approximately20%) surface expression as measured by binding of [3H]-ouabain (n = 3, p<0.01). (D-E) Conscious echocardiograms of wild-type and ankyrin-B+/- mice before and after transverse aortic constriction. Black labels represent wild-type animals, white labels represent ankyrin-B+/- data. Ankyrin-B+/- mice show preserved fractional shortening compared to wild-type mice over a wide range of hemodynamic stress (induced through transverse aortic constriction).
###end p 48
###begin p 49
###xml 148 152 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-MullerEhmsen1">[28]</xref>
###xml 154 158 154 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Wang1">[29]</xref>
###xml 273 274 273 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 331 342 331 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g002">Figure 2B&#8211;C</xref>
###xml 391 394 391 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 451 452 439 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 575 579 563 567 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max </sub>
###xml 620 623 608 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 625 628 613 616 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 660 669 648 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g002">Figure 2C</xref>
###xml 767 770 755 758 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 821 824 809 812 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 880 889 868 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g002">Figure 2C</xref>
###xml 1015 1016 987 988 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1026 1027 994 995 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1049 1052 1017 1020 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1088 1092 1056 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Mohler3">[14]</xref>
###xml 1207 1210 1175 1178 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1217 1221 1185 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Mohler3">[14]</xref>
###xml 1374 1377 1330 1333 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 219 224 <span type="species:ncbi:10090">mouse</span>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
There is considerable uncertainty regarding which isoforms of the Na/K ATPase are physiological targets for cardiac glycosides and in which species [28], [29]. Therefore we determined effects of ankyrin-B deficiency in mouse cardiomyocytes on the affinity and capacity for 3[H]-ouabain, which is a commonly used cardiac glycoside (Figure 2B-C). Freshly isolated cardiomyocytes from ankyrin-B+/- mice have reduced numbers (approximately15%) of surface 3H-ouabain-binding sites, but similar affinity for ouabain compared to cells derived from wild-type littermates (wild-type Bmax  = 1.90 pmol/mg (Kd = 31.3 nM); ankyrin-B+/- Bmax = 1.61 pmol/mg (Kd = 33.1 nM); Figure 2C). Scatchard plots reveal a single class of ouabain-binding sites for both wild-type and ankyrin-B+/- cells, suggesting that the sites lost in ankyrin-B+/- cells have the same affinity as the sites that remain (Figure 2C). These data with isolated cardiomyocytes are consistent with a approximately15% reduction in level of both Na/K ATPase alpha1 and alpha2 isoforms in ankyrin-B+/- heart tissue determined previously [14]. Na/K ATPase expression and localization at sarcolemmal and intercalated disc membranes is unaffected in ankyrin-B+/- cells [14]. Therefore, loss of T-tubule-associated Na/K ATPase is paralleled by loss of a small population of ouabain-binding sites (approximately16%) in ankyrin-B+/- cardiomyocytes that have the same affinity for ouabain as the residual binding sites.
###end p 49
###begin title 50
###xml 38 41 38 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
Enhanced cardiac function in ankyrin-B+/- mice
###end title 50
###begin p 51
###xml 113 116 113 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 172 175 172 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 403 407 403 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Glitsch1">[30]</xref>
###xml 725 729 725 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Rockman1">[22]</xref>
###xml 753 756 753 756 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 914 917 912 915 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 953 962 949 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g002">Figure 2D</xref>
###xml 1097 1106 1093 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g002">Figure 2E</xref>
###xml 1118 1121 1114 1117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1204 1213 1198 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g002">Figure 2D</xref>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
###xml 595 599 <span type="species:ncbi:10090">mice</span>
###xml 757 761 <span type="species:ncbi:10090">mice</span>
###xml 866 870 <span type="species:ncbi:10090">mice</span>
###xml 939 943 <span type="species:ncbi:10090">mice</span>
###xml 1122 1126 <span type="species:ncbi:10090">mice</span>
The finding that loss of ankyrin-B-coupled Na/K ATPase mimics effects of cardiac glycosides in isolated ankyrin-B+/- cardiomyocytes, suggested the hypothesis that ankyrin-B+/- mice also have enhanced cardiac function. Digitalis has a relatively subtle effect on the unstressed heart with a normal left ventricular (LV) pressure, and at one point was believed to only act in the context of heart failure [30]. We therefore measured left ventricular (LV) fractional shortening (an intact heart correlate of cellular shortening and one measure of cardiac function) by echocardiography in conscious mice before and after induction of LV pressure overload. LV pressure overload was induced by transverse aortic constriction (TAC; [22]). Before TAC, ankyrin-B+/- mice displayed a modest, but significant 10% increase in percent fractional shortening compared to wild-type mice (wild-type = 58.3+/-1.9%, n = 16; ankyrin-B+/- = 63.9+/-1.5% n = 15 mice; p<0.05; Figure 2D). Following TAC for seven days that induced similar increases in LV pressure overload as measured by the trans-stenotic gradient (see Figure 2E), ankyrin-B+/- mice exhibited preservation of higher fractional shortening (51.8+/-7.8%, n = 11; Figure 2D, p<0.05) compared to the striking approximately74% decline in fractional shortening to 29.8+/-7.9%, n = 9; p<0.05 observed in wild-type animals. Therefore, one benefit of loss of ankyrin-B-coupled Na/K ATPase is preservation of cardiac function under conditions of elevated afterload induced by hemodynamic stress.
###end p 51
###begin title 52
###xml 9 12 9 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
Ankyrin-B+/- mice display reduced sensitivity to ouabain-induced arrhythmia
###end title 52
###begin p 53
###xml 210 213 210 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 443 451 443 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g003">Figure 3</xref>
###xml 640 643 636 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 681 685 677 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Mohler3">[14]</xref>
###xml 782 791 778 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g003">Figure 3A</xref>
###xml 928 931 924 927 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1072 1081 1068 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g003">Figure 3C</xref>
###xml 1093 1096 1089 1092 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1221 1225 1217 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Hauptman1">[31]</xref>
###xml 214 218 <span type="species:ncbi:10090">mice</span>
###xml 601 605 <span type="species:ncbi:10090">mice</span>
###xml 644 648 <span type="species:ncbi:10090">mice</span>
###xml 776 780 <span type="species:ncbi:10090">mice</span>
###xml 797 801 <span type="species:ncbi:10090">mice</span>
###xml 943 947 <span type="species:ncbi:10090">mice</span>
###xml 1097 1101 <span type="species:ncbi:10090">mice</span>
Enthusiasm for clinical use of cardiac glycosides has subsided due to their capacity to promote fatal cardiac arrhythmias. The results with isolated adult cardiomyocytes suggested the possibility that ankyrin-B+/- mice might be at least partially resistant to proarrhythmic effects of ouabain. We evaluated effects of ouabain on heart rate and rhythm by measuring electrocardiograms in conscious animals using implanted wireless transmitters (Figure 3). Intraperitoneal injection of a low, sub-lethal dose of ouabain (100 microg/kg) leads to an expected modest decrease in heart rate in 6/6 wild-type mice tested, but no effect in ankyrin-B+/- mice, which already have bradycardia [14]. Lethal doses of ouabain (10 mg/kg) caused polymorphic arrhythmia in wild-type C57BL/6 WT mice (Figure 3A; 8/8 mice) within 16 minutes of injection, followed by death (6/8). Identical injections of lethal doses of ouabain to C57BL/6 ankyrin-B+/- littermate mice did result in decreased heart rate (8/8), but no significant ventricular arrhythmias (1/8), and, remarkably, no death (0/8; Figure 3C). Ankyrin-B+/- mice thus are resistant to ouabain in three functional readouts: reduction in heart rate, ventricular arrhythmia, and death [31].
###end p 53
###begin title 54
###xml 9 12 9 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
Ankyrin-B+/- mice are resistant to ouabain-induced ventricular arrhythmia and death.
###end title 54
###begin p 55
###xml 31 34 31 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 337 340 337 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 483 486 483 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 167 171 <span type="species:ncbi:10090">Mice</span>
###xml 322 326 <span type="species:ncbi:10090">mice</span>
###xml 341 345 <span type="species:ncbi:10090">mice</span>
###xml 501 505 <span type="species:ncbi:10090">mice</span>
###xml 605 609 <span type="species:ncbi:10090">mice</span>
Wild-type (n = 8) and ankyrin-B+/- mice (n = 8), and wild-type (n = 10) and phospholamban-null mice (n = 10) were surgically-implanted with radiotelemetry ECG probes. Mice were injected with a high dose (10 mg/kg) of ouabain or 2 mg/kg epinephrine, and conscious ECGs were recorded. Unlike wild-type or phospholamban-null mice, ankyrin-B+/- mice display resistance to ouabain-induced ventricular arrhythmia (1/8) and death (0/8). Panel A represents ECG data from wild-type, ankyrin-B+/-, and PLN null mice treated with ouabain. Data in panels B-D represent summary syncope, death, and arrhythmia data for mice following exercise (panel B), exercise plus epinephrine injection (panel C), and ouabain injection (panel D).
###end p 55
###begin p 56
###xml 9 12 9 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 228 231 216 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 237 241 225 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Mohler3">[14]</xref>
###xml 309 312 297 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 356 358 344 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 359 360 347 348 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 384 387 372 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 489 491 477 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 492 493 480 481 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 528 531 516 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 576 580 564 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Wolska1">[32]</xref>
###xml 621 623 609 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 867 876 855 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g003">Figure 3C</xref>
###xml 888 891 876 879 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1012 1014 1000 1002 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 313 317 <span type="species:ncbi:10090">mice</span>
###xml 455 459 <span type="species:ncbi:10090">mice</span>
###xml 532 536 <span type="species:ncbi:10090">mice</span>
###xml 682 686 <span type="species:ncbi:10090">mice</span>
###xml 823 827 <span type="species:ncbi:10090">mice</span>
###xml 850 854 <span type="species:ncbi:10090">mice</span>
###xml 892 896 <span type="species:ncbi:10090">mice</span>
Ankyrin-B+/- mice are not intrinsically resistant to all forms of arrhythmia since strenuous exercise plus injection of high doses of epinephrine caused ventricular arrhythmia, syncope, and death in approximately75% of ankyrin-B+/- mice [14]. However, a trivial explanation for ouabain-resistance of ankyrin-B+/- mice could be that chronic elevation of [Ca2+]i transients in ankyrin-B+/- cardiomyocytes caused compensatory adaptations. Phospholamban-null mice have chronic elevation of [Ca2+]i transients comparable to ankyrin-B+/- mice due to increased Ca-affinity of SERCA2 [32] and provide a control for generalized Ca2+-induced changes in protein expression. Phospholamban-null mice in a 129 background respond to high doses of ouabain with a similar arrhythmia (9/10) and death (8/10) in the same manner as C57BL/6 WT mice (8/8, 6/8) and 129 WT mice (9/10,8/10; Figure 3C). Ankyrin-B+/- mice thus are resistant to ouabain-induced cardiac arrhythmia due to a mechanism independent of adaptation to chronic Ca2+ elevation.
###end p 56
###begin title 57
###xml 9 12 9 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
Ankyrin-B+/- mice display premature senescence and reduced longevity
###end title 57
###begin p 58
###xml 188 191 188 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 292 295 292 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 336 347 336 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g004">Figure 4A&#8211;C</xref>
###xml 426 429 426 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 526 534 526 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g004">Figure 4</xref>
###xml 744 747 744 747 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 866 869 866 869 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 876 887 876 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g004">Figure 4A&#8211;C</xref>
###xml 889 902 889 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bottom panels</italic>
###xml 914 917 914 917 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 978 987 978 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g004">Figure 4D</xref>
###xml 1142 1151 1142 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g004">Figure 4F</xref>
###xml 1153 1157 1153 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Tyner1">[33]</xref>
###xml 1250 1253 1250 1253 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1400 1409 1400 1409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g004">Figure 4E</xref>
###xml 1447 1450 1447 1450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1526 1535 1526 1535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g004">Figure 4F</xref>
###xml 1561 1564 1561 1564 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1718 1722 1694 1698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Liang1">[34]</xref>
###xml 1984 1993 1960 1969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g001">Figure 1D</xref>
###xml 20 24 <span type="species:ncbi:10090">mice</span>
###xml 192 196 <span type="species:ncbi:10090">mice</span>
###xml 430 434 <span type="species:ncbi:10090">mice</span>
###xml 619 623 <span type="species:ncbi:10090">mice</span>
###xml 748 752 <span type="species:ncbi:10090">mice</span>
###xml 870 874 <span type="species:ncbi:10090">mice</span>
###xml 918 922 <span type="species:ncbi:10090">mice</span>
###xml 1254 1258 <span type="species:ncbi:10090">mice</span>
###xml 1451 1455 <span type="species:ncbi:10090">mice</span>
###xml 1565 1569 <span type="species:ncbi:10090">mice</span>
###xml 1832 1836 <span type="species:ncbi:10090">mice</span>
###xml 1920 1924 <span type="species:ncbi:10090">mice</span>
###xml 1942 1947 <span type="species:ncbi:9606">human</span>
As ankyrin-B mutant mice aged we noticed a consistent pattern of kyphosis, hair loss and general deterioration compared to their littermates. We therefore evaluated senescence in ankyrin-B+/- mice. Consistent with premature aging, we observed decreased soft tissue mass in >12 month ankyrin-B+/- animals (see 12 and 24 month animals in Figure 4A-C). In fact, when compared to their age-matched wild type littermates, ankyrin-B+/- mice demonstrate a loss of adiposity that begins at 6 months of age and progresses until death (Figure 4). This loss is not due to a decrease in food intake or core body temperature. These mice consume similar quantities of rodent chow, and have similar conscious body temperatures (not shown). Moreover, ankyrin-B+/- mice display severe kyphosis which begins at 6 months of age and becomes increasingly pronounced in two year ankyrin-B+/- mice, Figure 4A-C, bottom panels). Ankyrin-B+/- mice (>1 yr) also have an impaired ability to re-grow hair (Figure 4D). Hair growth requires functioning stem cells, suggesting these animals may have impaired stem cell regeneration, which can promote premature senescence (Figure 4F) [33]. Histological evaluation of the dorsal skin sections of two-year old wild-type and ankyrin-B+/- mice show a decrease in sub-dermal adipose tissue when compared with wild-type littermates, which also is a phenotype consistent with senescence (Figure 4E). Finally, the life-span of ankyrin-B+/- mice is significantly reduced compared with wild-type littermate controls (Figure 4F). Specifically, ankyrin-B+/- mice live on average to approximately90 weeks; while their wild-type littermates survive to approximately120 weeks (consistent with the C57Bl6 life-span [34]). These data demonstrate that accelerated aging is a highly penetrant consequence of ankyrin-B-deficiency in mice. A future goal will be to further explore the link between these longevity data in mice with preliminary human ankyrin-B variant data presented in Figure 1D.
###end p 58
###begin title 59
###xml 9 12 9 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
Ankyrin-B+/- mice display premature senescence and reduced longevity.
###end title 59
###begin p 60
###xml 43 46 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 257 260 257 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 348 351 348 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 540 543 540 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 705 708 705 708 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 782 785 782 785 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 831 834 831 834 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 261 265 <span type="species:ncbi:10090">mice</span>
###xml 352 356 <span type="species:ncbi:10090">mice</span>
###xml 611 615 <span type="species:ncbi:10090">mice</span>
###xml 786 791 <span type="species:ncbi:10090">mouse</span>
###xml 835 839 <span type="species:ncbi:10090">mice</span>
Gross phenotypes of wild-type and ankyrin-B+/- mice at (A) eight weeks, (B) six months, and C) two years. While we observe no major differences in phenotypes at eight weeks, we observe a slight decrease in size and the presence of lordokyphosis in ankyrin-B+/- mice at six months of age. At two years, unlike wild-type littermates, living ankyrin-B+/- mice display a significant decrease in adiposity and loss of soft tissues as well as prominent lordokyphosis. D, Dorsal hair regrowth phenotypes in 12 month C57Bl/6 wild-type and ankyrin-B+/- littermates. We observed no difference in regrowth in 1 or 3 month mice. E, H&E stain of dorsal skin sections from age-matched (24 month) wild-type and ankyrin-B+/- littermates. Note the decrease in adipose from the subdermis of ankyrin-B+/- mouse skin. F, Reduced longevity of ankyrin-B+/- mice compared with wild-type littermates.
###end p 60
###begin title 61
Ankyrin-B-haploinsufficiency in multiple cell types
###end title 61
###begin p 62
###xml 109 112 109 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 259 263 259 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Scotland1">[12]</xref>
###xml 265 269 265 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Tuvia1">[35]</xref>
###xml 445 448 445 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 455 466 455 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g005">Figure 5A&#8211;B</xref>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 449 453 <span type="species:ncbi:10090">mice</span>
As a first step in determining possible physiological differences underlie the complex phenotype of ankyrin-B+/- mice, we evaluated in these mice the pattern of expression of ankyrin-B. 220 kD ankyrin-B is abundantly expressed in both brain, heart and thymus [12], [35]. Ankyrin-B also is present at detectable levels in skeletal muscle, kidney, lung, testes, spleen and lung, and is reduced about 50 percent in all of these tissues in ankyrin-B+/- mice (Figure 5A-B).
###end p 62
###begin title 63
Ankyrin-B-haploinsufficiency in multiple cell types.
###end title 63
###begin p 64
###xml 129 132 129 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 288 291 288 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 941 944 941 944 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
###xml 133 138 <span type="species:ncbi:10090">mouse</span>
###xml 292 297 <span type="species:ncbi:10090">mouse</span>
###xml 481 486 <span type="species:ncbi:10090">mouse</span>
###xml 785 790 <span type="species:ncbi:10090">mouse</span>
###xml 945 949 <span type="species:ncbi:10090">mice</span>
A, Relative 220 kD ankyrin-B expression across mouse tissues. Right panel illustrates expression of 220 kD ankyrin-B in ankyrin-B+/- mouse tissues compared with wild-type littermate tissue (n>3, p<0.05). B, Quantitative immunoblot of 220 kD ankyrin-B expression in wild-type and ankyrin-B+/- mouse pancreas using ankyrin-B Ig. Protein levels were quantified by 125-labeled Protein A (n>3). C-D, Immunolocalization of glucagon (left) and ankyrin-B (right) in the Islet of wild-type mouse pancreas. Note that we observe no immunoreactivity of ankyrin-B in the exocrine pancreas. E, Immunolocalization of somatostatin and ankyrin-B in wild-type islets. We observe no co-expression of ankyrin-B and somatostatin in delta cells. F, Immunolocalization of glucagon and ankyrin-B in wild-type mouse islets. We observe no co-localization of glucagon and ankyrin-B in alpha cells. G, Immunolocalization of glucagon and ankyrin-B in Islets of ankyrin-B+/- mice. Note the significant decrease in ankyrin-B levels.
###end p 64
###begin p 65
###xml 187 196 187 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g005">Figure 5C</xref>
###xml 373 384 373 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g005">Figure 5D&#8211;E</xref>
###xml 463 466 460 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 477 492 474 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g005">Figure 5B, 5F&#8211;G</xref>
###xml 541 548 538 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Methods</italic>
###xml 644 647 641 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 855 864 848 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g005">Figure 5B</xref>
We next determined the cell types expressing ankyrin-B in several tissues. In the pancreas, ankyrin-B is highly expressed in islets and is virtually absent from surrounding acinar cells (Figure 5C). Within pancreatic islets, ankyrin-B staining was concentrated in beta cells and virtually absent from alpha cells (glucagon-positive) or delta cells (somatostatin-positive) (Figure 5D-E). Ankyrin-B immunostaining in beta-cells is significantly reduced in ankyrin-B+/- pancreas (Figure 5B, 5F-G). Identical labeling and imaging protocols (see Methods) revealed an approximate 47% decrease in the intensity ratio of ankyrin-B/glucagon in ankyrin-B+/- islets compared to wild-type islets (+/+, 0.90+/-0.1; +/-, 0.48+/-0.1, n = 20, p<0.05). As ankyrin-B expression in acinar cells is minimal, the reduction of ankyrin-B by quantitative immunoblot in pancreas (Figure 5B) is due primarily to loss of ankyrin-B in beta cells.
###end p 65
###begin p 66
###xml 338 342 338 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Mohler5">[16]</xref>
###xml 785 790 <span type="species:ncbi:10090">mouse</span>
In the heart, reduced expression of ankyrin B protein results in decreased levels of ankyrin-binding partners IP3 receptor, Na/Ca exchanger and Na/K ATPase. The loss of these channels/transporters in critical microdomains of cardiomyocyte transverse-tubules/sarcoplasmic reticulum is believed to be the basis of the arrhythmia phenotype. [16]. We determined that ankyrin-B haploinsufficiency also results in loss of IP3 receptor in other cell types, including Purkinje neurons in the cerebellum and bronchial epithelial cells in the lung as a correlate of ankyrin-B function in these cells (Figures S1,S2,S3). Future work will investigate the consequences of ankyrin-B deficiency at a molecular level, and determine which cell types contribute to the global phenotype of the ankyrin-B mouse.
###end p 66
###begin title 67
Discussion
###end title 67
###begin p 68
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANK2</italic>
###xml 437 441 437 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Mohler3">[14]</xref>
###xml 443 447 443 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Mohler4">[15]</xref>
###xml 486 489 486 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 897 900 897 900 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1046 1049 1046 1049 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 262 267 <span type="species:ncbi:9606">human</span>
###xml 281 285 <span type="species:ncbi:10090">Mice</span>
###xml 406 412 <span type="species:ncbi:9606">humans</span>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
###xml 901 905 <span type="species:ncbi:10090">mice</span>
###xml 1050 1054 <span type="species:ncbi:10090">mice</span>
This study reports that certain loss-of-function variants in the ANK2 gene are present in "normal" European and west African populations. The frequency of these variants is surprising given the high degree of protein conservation between species and within most human populations. Mice heterozygous for a null mutation in ankyrin-B have previously been demonstrated to have a similar cardiac arrhythmia as humans with ankyrin-B variants [14], [15]. Further characterization of ankyrin-B+/- mice in this paper reveal a heretofore unrecognized syndrome of increased cardiac contractility and resistance to cardiac glycoside-induced arrhythmia that is balanced by premature senescence. Ankyrin-B is co-expressed with IP3 receptors in specific cell types including Purkinje neurons and bronchial epithelial cells. Interestingly, both ankyrin-B and IP3 receptors are reduced in these cells in ankyrin-B+/- mice (Figures S1,S2,S3). Diminished function of IP3 receptors in calcium signaling thus may underlie some of the phenotypes observed in ankyrin-B+/- mice. Together, these findings suggest that the 2 percent of Europeans and up to 8 percent of individuals in west Africa that harbor specific ankyrin-B variants may respond favorably to digitalis treatments and also have increased risk of sudden cardiac death and diseases related to aging.
###end p 68
###begin p 69
###xml 22 25 22 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 212 215 212 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 340 344 340 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANK2</italic>
###xml 378 381 378 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
###xml 92 98 <span type="species:ncbi:9606">people</span>
###xml 216 220 <span type="species:ncbi:10090">mice</span>
###xml 235 240 <span type="species:ncbi:9606">human</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
###xml 491 497 <span type="species:ncbi:9606">humans</span>
Results with ankyrin-B+/- mice suggest several hypotheses that will be important to test in people. The high levels of ankyrin-B expression in the brain and pancreatic beta cells and early senescence in ankyrin-B+/- mice suggests that human populations with age-related neurological disorders and/or type 2 diabetes should be evaluated for ANK2 variants. Resistance of ankyrin-B+/- mice to ouabain-induced arrhythmia suggests that cardiac glycosides could be potentially used more safely in humans with ankyrin-B variants. Moreover, these findings suggest that interference with ankyrin-B function in the heart could be a potentially useful strategy to modify cardiac contractility.
###end p 69
###begin p 70
###xml 19 25 <span type="species:ncbi:9606">people</span>
###xml 617 621 <span type="species:ncbi:10090">mice</span>
8.6 percent of the people in our sample from Ghana are heterozygous for the L1622I gene variant. Therefore up to 0.7 percent of this population could be homozygous for the L1622I mutation in the absence of negative selection. While no individuals homozygous for the L1621I variant were detected in 384 individuals, this could result from the relatively small sample size. It will be of interest in the future to screen larger populations from Ghana as well as African Americans to determine if homozygous L1622I individuals exist, and if so whether they exhibit features of ankyrin-B syndrome characterized so far in mice.
###end p 70
###begin p 71
An obvious question is the nature of the benefit conveyed by certain ankyrin-B variants. Resistance to malaria is an unlikely factor, since ankyrin-B is not expressed in erythrocytes (not shown), or in vascular endothelial cells (Figure S2), and since variants are present in both Africans and Europeans. A simple hypothesis is that increased cardiac contractility enhances cardiac output during physical exertion, and thus improves survival. A corollary that can be experimentally tested is that athletes may be more likely to have ankyrin-B variants. Moreover, ankyrin-B variants may contribute to sudden cardiac death among young athletes.
###end p 71
###begin p 72
###xml 274 277 274 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 293 297 293 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Mohler3">[14]</xref>
###xml 496 500 496 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Nicholls1">[36]</xref>
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
A striking and highly penetrant effect of ankyrin-B deficiency in the mouse is a moderate reduction in life span accompanied by premature senescence in multiple tissues. One hypothesis to explain this phenotype is that disordered calcium homeostasis as observed in ankyrin-B+/- cardiomyocytes [14] results in mitochondrial stress. Inter-relationships between calcium, mitochondria, and aging have been attributed to accumulated damage from reactive oxygen due to calcium overload of mitochondria [36]. It will be important to evaluate effects of ankyrin-B deficiency and loss-of-function variants on mitochondrial function.
###end p 72
###begin p 73
###xml 19 22 19 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 130 139 130 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g002">Figures 2</xref>
###xml 140 140 140 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g003"/>
###xml 140 140 140 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g004"/>
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g005">5</xref>
###xml 143 147 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Mohler3">[14]</xref>
###xml 148 152 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Mohler5">[16]</xref>
###xml 154 158 154 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Tuvia1">[35]</xref>
###xml 209 217 209 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g005">Figure 5</xref>
###xml 392 395 392 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 402 411 402 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001051-g004">Figure 4D</xref>
###xml 517 521 517 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001051-Tuvia1">[35]</xref>
###xml 902 905 902 905 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
###xml 396 400 <span type="species:ncbi:10090">mice</span>
###xml 775 780 <span type="species:ncbi:10090">mouse</span>
###xml 906 911 <span type="species:ncbi:10090">mouse</span>
While the ankyrin-B+/- mouse model has been instrumental in demonstrating the role of ankyrin-B for normal vertebrate physiology (Figures 2-5; [14]-[16], [35]), the broad tissue distribution of ankyrin-B (see Figure 5) has greatly complicated the ability to precisely correlate animal phenotypes with specific tissue/cell dysfunction. For example, defects in dorsal hair regrowth in ankyrin-B+/- mice (Figure 4D) are indicative of impaired stem cell regeneration. However, since ankyrin-B is also expressed in thymus [35], an alternative hypothesis is that reduced ankyrin function in thymus results in reduced resistance to infection or even potential auto-immune defects associated with hair loss. A central future focus for the field will be to use genetically-engineered mouse and cell models to identify which specific cell types are responsible for the global phenotypes observed in the ankyrin-B+/- mouse.
###end p 73
###begin p 74
###xml 180 185 <span type="species:ncbi:10090">mouse</span>
In summary, this study demonstrates an unexpected prevalence of mutations in ankyrin-B that have been linked to risk for sudden cardiac death. We present the first evidence from a mouse model deficient in ankyrin-B that ankyrin-B variants can be viewed as balanced variants with increased risk of sudden death and early aging offset by increased cardiac contractility.
###end p 74
###begin title 75
Supporting Information
###end title 75
###begin p 76
###xml 124 128 <span type="species:ncbi:10090">mice</span>
InsP3R expression in Purkinje neurons is reduced in ankyrin-B+/- brain. Cerebellar sections from wild-type and ankyrin-B+/- mice were immunolabeled with affinity-purified antibody to (A) ankyrin-B and (B) InsP3R (pan). Wild-type and ankyrin-B +/- sections were prepared, stained, and imaged using identical protocols. Scale bar equals 50 microns.
###end p 76
###begin p 77
(5.10 MB TIF)
###end p 77
###begin p 78
Click here for additional data file.
###end p 78
###begin p 79
###xml 164 168 <span type="species:ncbi:10090">mice</span>
Ankyrin-B expression at the apical membrane of airway epithelial cells is significantly reduced in ankyrin-B+/- lung. Lung sections from wild-type and ankyrin-B+/- mice were immunolabeled with affinity-purified antibodies for beta-tubulin and ankyrin-B. No staining was observed using non-immune serum. Scale bars from top to bottom equal 100, 30, 100, and 25 microns. Wild-type and ankyrin-B+/- tissue sections were prepared and imaged identically. Abbreviations: Bronchus (Br), apical (ap), smooth muscle (sm), alveoli (al), artery (A).
###end p 79
###begin p 80
(3.19 MB TIF)
###end p 80
###begin p 81
Click here for additional data file.
###end p 81
###begin p 82
InsP3R expression is exclusively reduced in ankyrin-B+/- lung where co-expressed with ankyrin-B. InsP3R localization with co-labeling of beta-tubulin (columnar epithelial cells) in wild-type and ankyrin-B+/- lung sections. InsP3R (pan InsP3R) is highly expressed at the apical membrane of epithelial cells and in smooth muscle. No staining was observed using pre-immune serum. Bottom, reduction of ankyrin-B in ankyrin-B +/- lung is associated with InsP3R reduction at the apical membrane of epithelial cells, while there is no reduction in smooth muscle InsP3R. Scale bars from top to bottom equal 100, 20, 100, and 15 microns. Wild-type and ankyrin-B +/- tissue sections were prepared and imaged identically. Abbreviations: Bronchus (Br), apical (ap), smooth muscle (sm), alveoli (al), artery (A).
###end p 82
###begin p 83
(3.17 MB TIF)
###end p 83
###begin p 84
Click here for additional data file.
###end p 84
###begin p 85
###xml 83 86 83 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
We acknowledge Sarah K. Jones for maintenance and characterization of the ankyrin-B+/- animal colony.
###end p 85
###begin title 86
References
###end title 86
###begin article-title 87
###xml 83 88 <span type="species:ncbi:9606">human</span>
Purification of an active proteolytic fragment of the membrane attachment site for human erythrocyte spectrin.
###end article-title 87
###begin article-title 88
###xml 24 29 <span type="species:ncbi:9606">human</span>
Immunoreactive forms of human erythrocyte ankyrin are present in diverse cells and tissues.
###end article-title 88
###begin article-title 89
###xml 99 104 <span type="species:ncbi:9606">human</span>
Identification and partial purification of ankyrin, the high affinity membrane attachment site for human erythrocyte spectrin.
###end article-title 89
###begin article-title 90
Partial deficiency of erythrocyte spectrin in hereditary spherocytosis.
###end article-title 90
###begin article-title 91
Deficient red-cell spectrin in severe, recessively inherited spherocytosis.
###end article-title 91
###begin article-title 92
Ankyrin-1 mutations are a major cause of dominant and recessive hereditary spherocytosis.
###end article-title 92
###begin article-title 93
Ankyrin-G coordinates assembly of the spectrin-based membrane skeleton, voltage-gated sodium channels, and L1 CAMs at Purkinje neuron initial segments.
###end article-title 93
###begin article-title 94
AnkyrinG is required for clustering of voltage-gated Na channels at axon initial segments and for normal action potential firing.
###end article-title 94
###begin article-title 95
Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes.
###end article-title 95
###begin article-title 96
###xml 31 36 <span type="species:ncbi:9606">Human</span>
Lateral Membrane Biogenesis in Human Bronchial Epithelial Cells Requires 190-kDa Ankyrin-G.
###end article-title 96
###begin article-title 97
###xml 78 83 <span type="species:ncbi:9606">Human</span>
Ankyrin-G and beta2-Spectrin Collaborate in Biogenesis of Lateral Membrane of Human Bronchial Epithelial Cells.
###end article-title 97
###begin article-title 98
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Nervous system defects of AnkyrinB (-/-) mice suggest functional overlap between the cell adhesion molecule L1 and 440-kD AnkyrinB in premyelinated axons.
###end article-title 98
###begin article-title 99
###xml 66 71 <span type="species:ncbi:9606">human</span>
Defining the cellular phenotype of "ankyrin-B syndrome" variants: human ANK2 variants associated with clinical phenotypes display a spectrum of activities in cardiomyocytes.
###end article-title 99
###begin article-title 100
Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death.
###end article-title 100
###begin article-title 101
A cardiac arrhythmia syndrome caused by loss of ankyrin-B function.
###end article-title 101
###begin article-title 102
Ankyrin-B Coordinates the Na/K ATPase, Na/Ca Exchanger, and InsP(3) Receptor in a Cardiac T-Tubule/SR Microdomain.
###end article-title 102
###begin article-title 103
Molecular basis for PP2A regulatory subunit B56{alpha} targeting in cardiomyocytes.
###end article-title 103
###begin article-title 104
The Ankyrin-B C-terminal Domain Determines Activity of Ankyrin-B/G Chimeras in Rescue of Abnormal Inositol 1,4,5-Trisphosphate and Ryanodine Receptor Distribution in Ankyrin-B (-/-) Neonatal Cardiomyocytes.
###end article-title 104
###begin article-title 105
Low penetrance in the long-QT syndrome: clinical impact.
###end article-title 105
###begin article-title 106
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human genomics and its impact on arrhythmias.
###end article-title 106
###begin article-title 107
###xml 72 80 <span type="species:ncbi:9606">patients</span>
Targeted mutational analysis of ankyrin-B in 541 consecutive, unrelated patients referred for long QT syndrome genetic testing and 200 healthy subjects.
###end article-title 107
###begin article-title 108
###xml 112 118 <span type="species:ncbi:10090">murine</span>
Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy.
###end article-title 108
###begin article-title 109
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
Cellular and functional defects in a mouse model of heart failure.
###end article-title 109
###begin article-title 110
###xml 99 114 <span type="species:ncbi:10090">transgenic mice</span>
Defective beta-adrenergic receptor signaling precedes the development of dilated cardiomyopathy in transgenic mice with calsequestrin overexpression.
###end article-title 110
###begin article-title 111
###xml 124 128 <span type="species:ncbi:10090">mice</span>
Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice.
###end article-title 111
###begin article-title 112
Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction.
###end article-title 112
###begin article-title 113
Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo.
###end article-title 113
###begin article-title 114
###xml 36 41 <span type="species:ncbi:9606">human</span>
###xml 143 148 <span type="species:ncbi:4932">yeast</span>
Ouabain and substrate affinities of human Na(+)-K(+)-ATPase alpha(1)beta(1), alpha(2)beta(1), and alpha(3)beta(1) when expressed separately in yeast cells.
###end article-title 114
###begin article-title 115
###xml 4 9 <span type="species:ncbi:9606">human</span>
All human Na(+)-K(+)-ATPase alpha-subunit isoforms have a similar affinity for cardiac glycosides.
###end article-title 115
###begin article-title 116
Electrophysiology of the sodium-potassium-ATPase in cardiac cells.
###end article-title 116
###begin article-title 117
Digitalis.
###end article-title 117
###begin article-title 118
Effect of ablation of phospholamban on dynamics of cardiac myocyte contraction and intracellular Ca2+.
###end article-title 118
###begin article-title 119
###xml 11 15 <span type="species:ncbi:10090">mice</span>
p53 mutant mice that display early ageing-associated phenotypes.
###end article-title 119
###begin article-title 120
###xml 8 13 <span type="species:ncbi:10090">mouse</span>
Genetic mouse models of extended lifespan.
###end article-title 120
###begin article-title 121
Ankyrin-B is required for intracellular sorting of structurally diverse Ca2+ homeostasis proteins.
###end article-title 121
###begin article-title 122
Mitochondrial function and dysfunction in the cell: its relevance to aging and aging-related disease.
###end article-title 122
###begin p 123
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 123
###begin p 124
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: We acknowledge financial support from the NIH (HL084583 and HL083422 to PJM; HL-26057, HL-64018 and HL-77101 to EGK, HL056687 to HR). PJM is also supported by the Pew Charitable Trusts. VB acknowledges support from the Muscular Dystrophy Association.
###end p 124

